SQUAMOUS-CELL CARCINOMA OF THE PROSTATE - A TRANSFORMATION FROM ADENOCARCINOMA AFTER THE USE OF A LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST AND FLUTAMIDE

被引：19
作者：
BRASLIS, KG
DAVI, RC
NELSON, E
CIVANTOS, F
SOLOWAY, MS
机构：
[1] UNIV MIAMI,SCH MED,DEPT UROL,MIAMI,FL 33101
[2] UNIV MIAMI,SCH MED,DEPT PATHOL,MIAMI,FL 33101
来源：
UROLOGY | 1995年 / 45卷 / 02期
关键词：
D O I：
10.1016/0090-4295(95)80028-X
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.
引用
收藏
页码：329 / 331
页数：3
相关论文
共 50 条
12345